n advisory panel of the US Food and Drug Administration (FDA) dealt Procter & Gamble Co and Publicis Groupe a blow, recommending the agency reject P&G;�s female sex-drive patch Intrinsa.

P&G; executives had previously expressed optimism the testosterone patch would be approved for use in 2005. Various agencies affiliated with ad agency holding company Publicis Groupe had been picked to handle what would have been a high-profile launch campaign of a drug dubbed the "female Viagra", including Publicis Worldwide, New York, and Publicis-backed Amazon, San Francisco. ... more